These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 32200584)

  • 1. Basal and metoclopramide induced prolactin secretion in lean PCOS women.
    Mrozinska S; Przywara-Sikora A; Doroszewska K; Gałuszka-Bednarczyk A; Kiałka M; Guzik J; Janeczko M; Marianowski P; Dabrowski FA; Milewicz T
    Neuro Endocrinol Lett; 2019 Dec; 40(6):257-262. PubMed ID: 32200584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X; Lin JF
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PCOS Patients differ in Lipid Profile According to their Phenotypes.
    Spałkowska M; Mrozińska S; Gałuszka-Bednarczyk A; Gosztyła K; Przywara A; Guzik J; Janeczko M; Milewicz T; Wojas-Pelc A
    Exp Clin Endocrinol Diabetes; 2018 Jul; 126(7):437-444. PubMed ID: 29388179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothalamic dopaminergic tone and prolactin bioactivity in women with polycystic ovary syndrome.
    Hernández I; Parra A; Méndez I; Cabrera V; Cravioto MC; Mercado M; Díaz-Sánchez V; Larrea F
    Arch Med Res; 2000; 31(2):216-22. PubMed ID: 10880731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated anti-Mullerian hormone in lean women may not indicate polycystic ovarian syndrome.
    Bradbury RA; Lee P; Smith HC
    Aust N Z J Obstet Gynaecol; 2017 Oct; 57(5):552-557. PubMed ID: 28597496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
    Holte J; Bergh T; Gennarelli G; Wide L
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin secretion in polycystic ovary syndrome (PCOS).
    Szosland K; Pawlowicz P; Lewiński A
    Neuro Endocrinol Lett; 2015; 36(1):53-8. PubMed ID: 25789595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metoclopramide effect on serum prolactin LH and FSH in patients with polycystic ovary syndrome.
    Prelević GM; Würzburger MI; Perić LA
    J Endocrinol Invest; 1988 Apr; 11(4):255-9. PubMed ID: 3137253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basic and Meal Stimulated Plasma GIP Levels are Higher in Lean PCOS Women with FAI over 5.
    Milewicz T; Migacz K; Kiałka M; Rogatko I; Kowalczuk A; Spalkowska M; Mrozińska S; Czajkowska Z; Sztefko K
    Exp Clin Endocrinol Diabetes; 2016 Feb; 124(2):77-81. PubMed ID: 26895276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
    Daan NM; Jaspers L; Koster MP; Broekmans FJ; de Rijke YB; Franco OH; Laven JS; Kavousi M; Fauser BC
    Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycystic ovary syndrome and hyperprolactinemia are distinct entities.
    Filho RB; Domingues L; Naves L; Ferraz E; Alves A; Casulari LA
    Gynecol Endocrinol; 2007 May; 23(5):267-72. PubMed ID: 17558684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone, free testosterone, and free androgen index in women: Reference intervals, biological variation, and diagnostic value in polycystic ovary syndrome.
    Bui HN; Sluss PM; Hayes FJ; Blincko S; Knol DL; Blankenstein MA; Heijboer AC
    Clin Chim Acta; 2015 Oct; 450():227-32. PubMed ID: 26327459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Polycystic ovary syndrome associated with remarkable hyperprolactinemia--case report].
    Owecki M; Sowiński J
    Pol Merkur Lekarski; 2004 Oct; 17(100):385-7. PubMed ID: 15690710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of acute ACTH1-24 loading on the steroid hormone and prolactin content of the blood serum in women with hyperprolactinemia and hyperandrogenism].
    Dedov II; Mel'nichenko GA; Bol'shakova TD; Buniatian AF; Gitel' EP; Shilin DE; Nosova AA
    Probl Endokrinol (Mosk); 1990; 36(5):43-9. PubMed ID: 2080142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary response profile following metoclopramide administration in women with different forms of hyperprolactinemia.
    Espinós JJ; Vanrell C; Gich I; Urgell E; Calaf J
    Gynecol Endocrinol; 2017 Feb; 33(2):148-151. PubMed ID: 27841032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome.
    Glintborg D; Altinok M; Mumm H; Buch K; Ravn P; Andersen M
    Hum Reprod; 2014 Aug; 29(8):1773-9. PubMed ID: 24903198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the optimal prolactin cutoff for predicting the presence of a pituitary adenoma in patients with polycystic ovary syndrome?
    Kim SI; Yoon JH; Park DC; Yang SH; Kim YI
    Int J Med Sci; 2023; 20(4):463-467. PubMed ID: 37057215
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome.
    Yilmaz M; Biri A; Karakoç A; Törüner F; Bingöl B; Cakir N; Tiras B; Ayvaz G; Arslan M
    J Endocrinol Invest; 2005 Dec; 28(11):1003-8. PubMed ID: 16483179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of the free androgen index depends on the phenotype of polycystic ovary syndrome - a single-centre experience.
    Ożga K; Krzyczkowska-Sendrakowska M; Hubalewska-Dydejczyk A; Gilis-Januszewska A; Ratajczak M; Ratajczak M; Chaykivska Z; Jach R
    Endokrynol Pol; 2019; 70(4):330-335. PubMed ID: 30938834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperprolactinemia in children during the peripubertal period--personal observations.
    Noczyńska A; Wasikowa R
    J Pediatr Endocrinol Metab; 2004 Oct; 17(10):1399-404. PubMed ID: 15526718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.